TrialNeurology(R) neuroimmunology & neuroinflammation2025

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Jeffrey L Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.